Company · founded 2005
Gryphon Scientific (United States)
Takoma Park, United States · gryphonscientific.com
Part of Deloitte (United States)
- Citations, last 5 years
- 546
- Works, last 5 years
- 49
- h-index
- 95
- Scientists listed
- 6
- Grants since 2016
- 22
Grants received
2024–2025 · contract · N01
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Development of Novel sgp130-Fc Bioconjugates for TBI
William E Haskins · Gryphon Scientific (United States) · funded by National Institutes of Health
2023–2026 · grant · AZRP
Highly Scalable and Cost-Effective Home-Based Sampling and Testing Solution for Glymphatic Clearance/Impairment in TBI Veterans at Risk for Alzheimer's Disease
William Haskins · Gryphon Scientific (United States) · funded by Congressionally Directed Medical Research Programs
2023–2024 · contract · N01
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2023–2027 · research · R44
Development of Novel sgp130-Fc Bioconjugates for TBI
William E Haskins · Gryphon Scientific (United States) · funded by National Institutes of Health
2022–2026 · grant · TBIPH
Feasibility Study of A Single-Platform Solution for Blood Testing of TBI Biomarkers
William Haskins · Gryphon Scientific (United States) · funded by Congressionally Directed Medical Research Programs
2022–2023 · contract · N43
SYSTEMATIC UNDERSTANDING AND ELIMINATION OF MISINFORMATION ONLINE
James Nolan · Gryphon Scientific (United States) · funded by National Institutes of Health
2021–2022 · contract · N01
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2021–2024 · research · R44
Temporal Biomarker-Powered Immunotherapy Targeting GFAP for Traumatic Brain Injury
William E Haskins · Gryphon Scientific (United States) · funded by National Institutes of Health
2021–2026 · grant · AZRP
Modular Design-Accelerated Development of Minimally Invasive Dried Plasma and Saliva Tests for Detecting TBI Sequelae for AD Dementia
William Haskins · Gryphon Scientific (United States) · funded by Congressionally Directed Medical Research Programs
2021–2022 · contract · N01
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2020–2021 · research · R44
Interactive Training in Emergency Operations for the Response Community
Gautham Venugopalan · Gryphon Scientific (United States) · funded by National Institutes of Health
2020–2021 · contract · N01
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2020–2021 · research · R43
Preventing Opioid Exposure Training (POET) for First Responders
Margaret Andrews Rush · Gryphon Scientific (United States) · funded by National Institutes of Health
2019–2020 · contract · N01
ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
Louise Sumner · Gryphon Scientific (United States) · funded by National Institutes of Health
2019–2023 · grant · AZRP
Anti-Tau DNA Aptamers: Robust Research Resources for Precision Medicines for TBI-Linked AD/ADRD
William Haskins · Gryphon Scientific (United States) · funded by Congressionally Directed Medical Research Programs
2019–2021 · research · R43
Preventing Opioid Exposure Training (POET) for First Responders
Margaret Andrews Rush · Gryphon Scientific (United States) · funded by National Institutes of Health
2018–2019 · contract · N01
ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
Rocco Casagrande · Gryphon Scientific (United States) · funded by National Institutes of Health
2017–2018 · contract · N01
ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
Rocco Casagrande · Gryphon Scientific (United States) · funded by National Institutes of Health
2016–2017 · contract · N01
IGF::OT::IGF ANALYSIS OF CHEMICAL STRUCTURES AND THERAPEUTIC ACTIVITY OF AGENTS FOR HIV AND TUBERCULOSIS (CHEMDB)
Rocco Casagrande · Gryphon Scientific (United States) · funded by National Institutes of Health
2015–2020 · research · R44
Interactive Training in Emergency Operations for the Response Community
Gautham Venugopalan · Gryphon Scientific (United States) · funded by National Institutes of Health
2015–2021 · research · R44
Interactive Training in Emergency Operations for the Response Community
Gautham Venugopalan · Gryphon Scientific (United States) · funded by National Institutes of Health